Dexamethasone: A boon for critically ill COVID-19 patients?

Travel Med Infect Dis. 2020 Sep-Oct:37:101844. doi: 10.1016/j.tmaid.2020.101844. Epub 2020 Aug 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Critical Illness
  • Dexamethasone / therapeutic use*
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • Anti-Inflammatory Agents
  • Dexamethasone